One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Dermatology Societies Should Explore Fossil Fuel Divestment
Raj P. Fadadu, MS; Mary L. Williams, MD; Misha Rosenbach, MD
doi : 10.1001/jamadermatol.2022.3902
October 2022, Vol 158, No. 10, Pages 1101-1221
Future Potential of 2-Photon Fluorescence Microscopy in Mohs and General Dermatology Practice
Abigail Waldman, MD; Conor L. Evans, PhD
JAMA Dermatology’s Commitment to Diversity, Equity, and Inclusion
Mya L. Roberson, MSPH, PhD; Adewole S. Adamson, MD, MPP; Kanade Shinkai, MD, PhD; et al.
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis
Zenas Z. N. Yiu, PhD; Gabrielle Becher, MD; Brian Kirby, MD; et al.
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records
Carla L. Zema, PhD; Wendell C. Valdecantos, MD; Jonathan Weiss, MS; et al.
Multivariable Predictive Models to Identify the Optimal Biologic Therapy for Treatment of Patients With Psoriasis at the Individual Level
Mia-Louise Nielsen, MSc; Troels Christian Petersen, PhD; Julia-Tatjana Maul, MD; et al.
Association Between Low-Dose Methotrexate Exposure and MelanomaA Systematic Review and Meta-analysis
Mabel K. Yan, MBBS; Charlie Wang, MBBS; Rory Wolfe, PhD; et al.
Clinical and Pathological Characteristics and Outcomes Among Patients With Subcutaneous Panniculitis-like T-Cell Lymphoma and Related Adipotropic Lymphoproliferative Disorders
Joan Guitart, MD; Aaron R. Mangold, MD; Maria Estela Martinez-Escala, MD, PhD; et al.
Real-time Analysis of Skin Biopsy Specimens With 2-Photon Fluorescence Microscopy
Vincent D. Ching-Roa, MS; Chi Z. Huang, MS; Sherrif F. Ibrahim, MD, PhD; et al.
Quality and Perceived Usefulness of Patient-Submitted Store-and-Forward Teledermatology Images
Simon W. Jiang, BS; M. Seth Flynn, BS; Jeffery T. Kwock, MD; et al.
Shared Decision-Making, Therapeutic Choice, and Decisional Regret in Patients With Alopecia Areata
Sophia Reyes-Hadsall, BS; Lara Drake, BA; Jane J. Han, BS; et al.
Evidence-Based Clinical Practice Guidelines for Laser-Assisted Drug Delivery
Jessica G. Labadie, MD; Sarah A. Ibrahim, MD; Brandon Worley, MD; et al.
Nail Sarcoidosis
Rachael Ward, MD, MPH; Andrea Kalus, MD; April Schachtel, MD
Monkeypox Infection
Rafael Escudero-Tornero, MD; Tristán-Gabriel Sobral-Costas, MD; Guillermo Servera-Negre, MD
A Rapidly Enlarging Facial Abscess
Brandon Levian, BA; Alessandra Chen, MD; Brandon L. Adler, MD
Proton Pump Inhibitors Associated With Drug-Induced Lupus Erythematosus
Pauline Bataille, MD; Bénédicte Lebrun-Vignes, MD; Florence Tubach, MD, PhD; et al.
Differences in Face-to-Face Time Spent With a Dermatologist Among Patients With Psoriasis Based on Race and Ethnicity
Kevin K. Wu, MD; April W. Armstrong, MD, MPH
Prevalence of Leukopenia and Associated Outcomes in Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
Leo L. Wang, MD, PhD; Megan H. Noe, MD, MPH, MSCE; Robert G. Micheletti, MD
Neurofibromatosis Type 1 and Risk of Skin Cancer
Pavin Trinh, BS; Shufeng Li, MS; Kavita Yang Sarin, MD, PhD
Cutaneous Herpetiform Ulcerations as the Presenting Sign of an Acute Aortic Occlusion
Ryan Sacotte, MD; Ashaki Patel, MD; Karolyn A. Wanat, MD; et al.
Botulinum Toxin A for the Treatment of Yellow Nail Syndrome and Palmar Primary Hyperhidrosis
Anqi Li, MD; Qiuning Sun, MD
Why Increased Diversity in Dermatologic Clinical Trials Is Not Inherently Ethical—An Evidence-Based, Community-Engaged Approach to Diverse Trial Recruitment
Emmanuella Ngozi Asabor, MPhil; Jeffrey M. Cohen, MD; Jaya Aysola, MD, DTMH, MPH
Comorbidities in Korean Patients With Palmoplantar Pustulosis vs Psoriasis Vulgaris or Pompholyx
Kazuki Yatsuzuka, MD; Masamoto Murakami, MD, PhD
Comorbidities in Korean Patients With Palmoplantar Pustulosis vs Psoriasis Vulgaris or Pompholyx—Reply
Dong Hyo Kim, MD; Soo Ick Cho, MD, PhD; Seong Jin Jo, MD, PhD
